Digital Investor Conferences MELBOURNE, Australia and SAN FRANCISCO, June 20, 2022 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Firm”), a biotechnology firm devoted to growing…
Digital Investor Conferences MELBOURNE, Australia and SAN FRANCISCO, June 20, 2022 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Firm”), a biotechnology firm devoted to growing…